2011
DOI: 10.1097/iae.0b013e3181eef031
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Segmentation Procedures Using Spectral Domain Optical Coherence Tomography in Exudative Age-Related Macular Degeneration

Abstract: Automated algorithms of SD-OCT demonstrate a substantial rate of alignment failures in the assessment of exudative age-related macular degeneration pathologies, which are usually associated with misinterpretation of boundaries at the (sub) RPE level.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0

Year Published

2012
2012
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 17 publications
1
11
0
Order By: Relevance
“…Such errors in the automated detection of Bruch’s membrane induce wrong quantification of retinal thickness and may lead to erroneous decision of retreatment. Based on this automated retinal thickness, our findings are comparable to results previously obtained with Cirrus SD-OCT and Spectralis SD-OCT [21,25,26,27]. While the inner limiting membrane is always well defined, Bruch’s membrane was poorly defined in several cases, particularly in geographic atrophy [28].…”
Section: Discussionsupporting
confidence: 77%
“…Such errors in the automated detection of Bruch’s membrane induce wrong quantification of retinal thickness and may lead to erroneous decision of retreatment. Based on this automated retinal thickness, our findings are comparable to results previously obtained with Cirrus SD-OCT and Spectralis SD-OCT [21,25,26,27]. While the inner limiting membrane is always well defined, Bruch’s membrane was poorly defined in several cases, particularly in geographic atrophy [28].…”
Section: Discussionsupporting
confidence: 77%
“…These machines do not differentiate subretinal fluid (SRF) from neurosensory retina, nor do they separately quantify subretinal hyperreflective material (SRHM) or pigment epithelial detachment (PED). The measurements from volume maps generated using OCT can also be affected by artifacts, [14][15][16][17] poor signal, 18 operator errors, and decentration owing to poor fixation. 19 Even newer third-party automated algorithms for CNV lesions require human input and optimization.…”
Section: Introductionmentioning
confidence: 99%
“…21 We have also previously demonstrated that accurate retinal thickness and volume maps can be generated using only a small subset of B-scans (32 B-scans) in a volume cube; 13,20 however, this study included retinal pathologies of various origins and not specifically CNV, wherein significant disruption of the outer retina leads to more frequent and severe segmentation errors. 16,18,22 Furthermore, the accuracy of volumes of more localized pathologic features, such as PED or SRF, may be more severely compromised by lower sampling densities. Thus, in the present study, we address these issues by evaluating the impact of reduced B-scan frame sampling, specifically in eyes with neovascular AMD, and incorporating CNV lesion parameters such as SRF, SRHM, and PED.…”
Section: Introductionmentioning
confidence: 99%
“…They found that RPE and ILM segmentation were excellent in both scan patterns, and severe failures were less common with the 200 × 200 raster scan pattern. 21 For this reason, we decided to use both of the Cirrus SD-OCT scan options in our study. The choice of scan patterns on the Spectralis OCT is not known to have an effect on the segmentation, which is consistent with the fact that the algorithm works on each B-scan separately.…”
Section: Discussionmentioning
confidence: 99%
“…A change in the retinal thickness measurement along with qualitative assessment of the B-scans is often used to determine re-treatment in eyes undergoing anti-VEGF therapy, and vascularized PEDs are often a component of the neovascular lesions. [19][20][21][22] Due to the importance of retinal thickness measurements in the presence of PEDs when re-treating patients with anti-VEGF therapy and when recruiting patients with neovascular AMD into clinical studies, we evaluated the segmentation performance of two SD-OCT instruments, the Cirrus SD-OCT (Carl Zeiss Meditec, Dublin, CA) and the Spectralis OCT (Heidelberg Engineering, Heidelberg, Germany) in patients with PEDs.…”
Section: Discussionmentioning
confidence: 99%